SELLAS Life Sciences Group, Inc.
SELLAS Life Sciences Group, Inc. (SLS) Stock Overview
Key statistics and deep links to earnings, valuation, revenue, dividends, and more.
FMP · SLS · as of Jun 9, 2026
Key Statistics
Explore SELLAS Life Sciences Group, Inc. Data
sls stock data · financialsFinancial Snapshot
Full FinancialsAnalyst Ratings & Price Target
Full ForecastTotal: 5 · Buy rate: 100.0%
The SLS analyst consensus is Buy, based on ratings from 5 Wall Street analysts over the past 3 months. The average 12-month price target is $2.80, representing -64.91% downside from the current price of $7.98.
Competitors & Peers
sls competitorsSLS
ARMP
CCCC
CDXS
GNFT
IVVDStock Performance
Full HistoryAbout SELLAS Life Sciences Group, Inc.
SELLAS Life Sciences Group, Inc. operates as a late-stage biopharmaceutical entity, dedicated to advancing novel cancer immunotherapies for various cancer indications across the United States. Its pri…
what is sellas life sciences group, inc. · sls stock overview · sellas life sciences group, inc. company profile · who is sellas life sciences group, inc. ceo · sls NASDAQ · sellas life sciences group, inc. headquarters · sellas life sciences group, inc. business segments
About Stock Overview & Key Data
SELLAS Life Sciences Group, Inc. (SLS) is a Healthcare company in the Biotechnology industry, listed on NASDAQ since Mar 12, 2008. As of the latest trading session, SLS stock price is $7.98, with a market capitalization of $1.1B. The stock has returned +408.28% over the past 12 months and +111.67% year-to-date.
According to 5 Wall Street analysts, the consensus rating for SELLAS Life Sciences Group, Inc. stock is Buy, with an average 12-month price target of $2.80. In fiscal year 2025, SELLAS Life Sciences Group, Inc. reported revenue of — and net income of -$26.9M. For detailed data — including SELLAS Life Sciences Group, Inc. revenue history, earnings, dividends, and PE ratio — use the tabs above.
Frequently Asked Questions
As of the latest trading session, SELLAS Life Sciences Group, Inc. (SLS) stock price is $7.98. The stock is traded on NASDAQ under the ticker symbol SLS. The 52-week range is $1.39 – $9.51.